Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells

scientific article

Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/IGC.0B013E31824F0B13
P698PubMed publication ID22672985

P50authorHiroaki ItamochiQ88144724
Muneaki ShimadaQ88144741
Shinya SatohQ91398017
Tasuku HaradaQ92368070
Tetsuro OishiQ93005904
Junzo KigawaQ95979461
Naoki TerakawaQ114357111
Akiko KudohQ117263162
Kazunori UegakiQ117263166
Wakae KawaguchiQ117266174
P2093author name stringMichiko Nonaka
Seiya Sato
Jun Naniwa
P433issue6
P921main subjectcisplatinQ412415
ovarian carcinomaQ18556145
P304page(s)922-929
P577publication date2012-07-01
P1433published inInternational Journal of Gynecological CancerQ15749181
P1476titleActivation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells
P478volume22

Reverse relations

cites work (P2860)
Q36689029Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells
Q38179145MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Q37165926New strategy for overcoming resistance to chemotherapy of ovarian cancer.
Q39173323Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Q34669870Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
Q28540458Retracted: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
Q28066950Role of Akt signaling in resistance to DNA-targeted therapy
Q40751673Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.
Q40714885Tempol protects human lymphocytes from genotoxicity induced by cisplatin
Q92556126Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway

Search more.